Fundraising Masterclass: Health tech traction w Marko Kuisma
Fundraising Masterclass: Health Tech Validation Before Fundraising
When your product still needs regulatory sign-off or years of clinical work before it generates revenue, what actually convinces an investor to write a check?
Marko Kuisma, Partner at Innovestor Life Sciences, joins us to unpack exactly that. He'll walk through what health tech and life sciences investors look for at each stage; from pre-seed to Series A.
Expect a practical breakdown of:
Regulatory milestones that function as proof points, and which ones actually matter to investors
Clinical validation what stage of evidence de-risks a deal enough to unlock funding
Non-dilutive funding (grants, contracts) as a signal of credibility, not just capital
How "traction" evolves across rounds:
What's enough at pre-seed vs. what Series A investors expect to see.
If you're building in health tech or life sciences and wondering what to show when revenue isn't the story yet, this session is built for you.